{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:45:42Z","timestamp":1712191542543},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologie"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00120-023-02266-3","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T11:47:19Z","timestamp":1706183239000},"page":"367-372","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Das lymphonodul\u00e4r metastasierte Peniskarzinom: eine uroonkologische Herausforderung\u00a0\u2013 die leitlinienorientierte Therapie","Lymph node metastatic penile cancer: a\u00a0challenge in uro-oncology\u2014guideline-conform treatment"],"prefix":"10.1007","volume":"63","author":[{"given":"D. L.","family":"Dr\u00e4ger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Nolting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pohla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. W.","family":"Hakenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,25]]},"reference":[{"key":"2266_CR1","unstructured":"(2018) World health organization. Cancer today. https:\/\/gco.iarc.fr\/today\/home. Zugegriffen: 5. M\u00e4rz 2020"},{"key":"2266_CR2","first-page":"e117","volume":"41","author":"CG-P Montes Cardona","year":"2017","unstructured":"Montes Cardona\u00a0CG\u2011P (2017) HA, Incidence of penile cancer worldwide: systematic review and meta-analysis. Rev Panam Salud Publica 41:e117","journal-title":"Rev Panam Salud Publica"},{"key":"2266_CR3","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s00761-019-00662-z","volume":"25","author":"C Protzel","year":"2019","unstructured":"Protzel\u00a0C, Hakenberg\u00a0O (2019) Peniskarzinom \u2013 Diagnose und Therapie. Onkologe 25:1027\u20131040","journal-title":"Onkologe"},{"key":"2266_CR4","first-page":"646","volume":"115","author":"OW Hakenberg","year":"2018","unstructured":"Hakenberg\u00a0OW, Draeger\u00a0DL, Erbersdobler\u00a0A, Naumann\u00a0CM, Juenemann\u00a0KP, Protzel\u00a0C (2018) The diagnosis and treatment of penile cancer. Dtsch Artzebl Int 115:646\u2013652","journal-title":"Dtsch Artzebl Int"},{"key":"2266_CR5","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Diagnostik, Therapie und Nachsorge des Peniskarzinoms, Langversion 1.0, 2020, AWMF Registernummer: 043-042OL. https:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/peniskarzinom\/. Zugegriffen: 9. Mai 2022"},{"issue":"1","key":"2266_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000176016","volume":"82","author":"C Protzel","year":"2009","unstructured":"Protzel\u00a0C, Hakenberg\u00a0OW (2009) Chemotherapy in patients with penile carcinoma. Urol Int 82(1):1\u20137","journal-title":"Urol Int"},{"key":"2266_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/cpt.911","volume":"103","author":"U Amstutz","year":"2018","unstructured":"Amstutz\u00a0U et\u00a0al (2018) Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update. Clin Pharmacol Ther 103:210\u2013216","journal-title":"Clin Pharmacol Ther"},{"key":"2266_CR8","unstructured":"(2020) DGHO Positionspapier Dihydropyrimidin-Dehydrogenase (DPD) \u2013 Testung vor Einsatz von 5\u2011Fluorouracil, Capecitabin und Tegafur. https:\/\/www.dgho.de\/publikationen\/stellungnahmen\/gute-aerztliche-praxis\/dpd-testung\/dpd-positionspapier-2020-konsens_logos_final.pdf\/view"},{"issue":"1","key":"2266_CR9","first-page":"26","volume":"57","author":"DL Draeger","year":"2018","unstructured":"Draeger\u00a0DL, Heuschkel\u00a0M, Protzel\u00a0C, Erbersdobler\u00a0A, Krause\u00a0BJ, Hakenberg\u00a0OW, Schwarzenb\u00f6ck\u00a0SM (2018) The 18F-FDG-PET\/CT for assessing inguinal lymph nodes metastases in patients with localized penile cancer\u2014correlation with histopathology after inguinal lymphadenectomy. Nuklearmedizin 57(1):26\u201330","journal-title":"Nuklearmedizin"},{"issue":"2","key":"2266_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/bju.12993","volume":"117","author":"P Kirrander","year":"2016","unstructured":"Kirrander\u00a0P et\u00a0al (2016) Swedish national penile cancer register: incidence, tumour characteristics, management and survival. BJU Int 117(2):287\u2013292","journal-title":"BJU Int"},{"issue":"4","key":"2266_CR11","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.juro.2013.10.140","volume":"191","author":"G Lughezzani","year":"2014","unstructured":"Lughezzani\u00a0G et\u00a0al (2014) The relationship between characteristics of inguinal lymph nodes and pelvic lymph node involvement in penile squamous cell carcinoma: a\u00a0single institution experience. J\u00a0Urol 191(4):977\u2013982","journal-title":"J Urol"},{"issue":"3","key":"2266_CR12","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0022-5347(17)36126-8","volume":"149","author":"S Horenblas","year":"1993","unstructured":"Horenblas\u00a0S et\u00a0al (1993) Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. J\u00a0Urol 149(3):492\u2013497","journal-title":"J Urol"},{"issue":"6b","key":"2266_CR13","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3109\/02841868809094366","volume":"27","author":"G Pizzocaro","year":"1988","unstructured":"Pizzocaro\u00a0G, Piva\u00a0L (1988) Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol 27(6b):823\u2013824","journal-title":"Acta Oncol"},{"issue":"1","key":"2266_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","volume":"67","author":"OW Hakenberg","year":"2015","unstructured":"Hakenberg\u00a0OW, Comp\u00e9rat\u00a0EM, Minhas\u00a0S, Necchi\u00a0A, Protzel\u00a0C, Watkin\u00a0N (2015) EAU-guidelines penile cancer: update 2014. Eur Urol 67(1):142\u2013150","journal-title":"Eur Urol"},{"key":"2266_CR15","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.urology.2014.12.049","volume":"85","author":"J Wang","year":"2015","unstructured":"Wang\u00a0J, Pettaway\u00a0CA, Pagliaro\u00a0LC (2015) Treatment for metastatic penile cancer after first-line chemotherapy failure: analysis of response and survival outcomes. Urology 85:1104\u20131110","journal-title":"Urology"},{"issue":"1","key":"2266_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.eururo.2008.04.016","volume":"54","author":"JA Leijte","year":"2008","unstructured":"Leijte\u00a0JA et\u00a0al (2008) Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a\u00a0two-centre analysis of 700 patients. Eur Urol 54(1):161\u2013168","journal-title":"Eur Urol"},{"issue":"578","key":"2266_CR17","first-page":"e11","volume":"37","author":"FA Mistretta","year":"2019","unstructured":"Mistretta\u00a0FA, Mazzone\u00a0E, Palumbo\u00a0C, Knipper\u00a0S, Tian\u00a0Z (2019) Nazzani S et a. Adherence to giudeline recommendations for lymph node dissection in squamous cell carcinoma of the penis: effect on survival and complication rates. Urol Oncol 37(578):e11\u2013e19","journal-title":"Urol Oncol"},{"key":"2266_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2020.02.005","author":"R Suarez-Ibarrola","year":"2020","unstructured":"Suarez-Ibarrola\u00a0R, Zengerling\u00a0F, Haccius\u00a0M, Lebentrau\u00a0S, Schmid\u00a0HP, Bier\u00a0M et\u00a0al (2020) Adherence to European association of urology and national comprehensive cancer network guidelines criteria for inguinal and pelvic lymph node dissection in penile cancer patients\u2014a\u00a0survey assessment in German-speaking countries on behalf of the European prospective penile cancer study group. Eur Urol Focus. https:\/\/doi.org\/10.1016\/j.euf.2020.02.005","journal-title":"Eur Urol Focus"}],"container-title":["Die Urologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-023-02266-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-023-02266-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-023-02266-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T10:04:30Z","timestamp":1712138670000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-023-02266-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["2266"],"URL":"https:\/\/doi.org\/10.1007\/s00120-023-02266-3","relation":{},"ISSN":["2731-7064","2731-7072"],"issn-type":[{"value":"2731-7064","type":"print"},{"value":"2731-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,25]]},"assertion":[{"value":"15 December 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"D.L.\u00a0Dr\u00e4ger, J.\u00a0Nolting, M.\u00a0Pohla und O.W.\u00a0Hakenberg geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}